Lemara tablets contain an active substance called letrozole. It belongs to a group of medicines called
aromatase inhibitors. It is a hormonal (or “endocrine”) breast cancer treatment. Growth of breast cancer
is frequently stimulated by oestrogens which are female sex hormones. Lemara reduces the amount of
oestrogen by blocking an enzyme (“aromatase”) involved in the production of oestrogens and therefore
may block the growth of breast cancer that needs oestrogens to grow. As a consequence, tumour cells
slow or stop growing and/or spreading to other parts of the body.
|Business Partner||MYLAN SAS|